Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Tomelleri

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Autoimmunity Reviews|August 25, 2023
Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?Carlo Salvarani, Roberto Padoan, Luca Iorio, et al.
Rheumatology (Oxford, England)|February 8, 2020
Clinically isolated aortitis successfully treated with methotrexate monotherapySilvia Sartorelli, Alessandro Tomelleri, Anna Palmisano, et al.
Seminars in Arthritis and Rheumatism|February 24, 2020
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritisCorrado Campochiaro, Alessandro Tomelleri, Silvia Sartorelli, et al.
Frontiers in Immunology|June 19, 2018
Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester DiseaseAlessandro Tomelleri, Giulio Cavalli, Giacomo De Luca, et al.
Seminars in Arthritis and Rheumatism|December 19, 2020
Drug retention rates of biological agents in adult onset Still's diseaseCorrado Campochiaro, Nicola Farina, Alessandro Tomelleri, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 22, 2021
Long-Term Efficacy and Safety of Leflunomide in Large-Vessel Giant Cell Arteritis: A Single-Center, 10-Year ExperienceAlessandro Tomelleri, Fiona Coath, Alwin Sebastian, et al.
Frontiers in Immunology|April 9, 2021
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac InvolvementGiacomo De Luca, Giulio Cavalli, Corrado Campochiaro, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2022
Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case seriesCorrado Campochiaro, Alessandro Tomelleri, Giulio Cavalli, et al.
Arthritis Research & Therapy|February 27, 2019
Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still's diseaseGiulio Cavalli, Alessandro Tomelleri, Giacomo De Luca, et al.
Modern Rheumatology|December 11, 2021
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohortAlessandro Tomelleri, Corrado Campochiaro, Silvia Sartorelli, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Autoimmunity Reviews|August 25, 2023
Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?Carlo Salvarani, Roberto Padoan, Luca Iorio, et al.
Rheumatology (Oxford, England)|February 8, 2020
Clinically isolated aortitis successfully treated with methotrexate monotherapySilvia Sartorelli, Alessandro Tomelleri, Anna Palmisano, et al.
Seminars in Arthritis and Rheumatism|February 24, 2020
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritisCorrado Campochiaro, Alessandro Tomelleri, Silvia Sartorelli, et al.
Frontiers in Immunology|June 19, 2018
Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester DiseaseAlessandro Tomelleri, Giulio Cavalli, Giacomo De Luca, et al.
Seminars in Arthritis and Rheumatism|December 19, 2020
Drug retention rates of biological agents in adult onset Still's diseaseCorrado Campochiaro, Nicola Farina, Alessandro Tomelleri, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 22, 2021
Long-Term Efficacy and Safety of Leflunomide in Large-Vessel Giant Cell Arteritis: A Single-Center, 10-Year ExperienceAlessandro Tomelleri, Fiona Coath, Alwin Sebastian, et al.
Frontiers in Immunology|April 9, 2021
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac InvolvementGiacomo De Luca, Giulio Cavalli, Corrado Campochiaro, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2022
Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case seriesCorrado Campochiaro, Alessandro Tomelleri, Giulio Cavalli, et al.
Arthritis Research & Therapy|February 27, 2019
Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still's diseaseGiulio Cavalli, Alessandro Tomelleri, Giacomo De Luca, et al.
Modern Rheumatology|December 11, 2021
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohortAlessandro Tomelleri, Corrado Campochiaro, Silvia Sartorelli, et al.
Pageof 13